Is hidden cartilage damage driving my knee pain

Ongoing knee pain after an ACL or meniscus operation, or an MRI line that mentions “chondromalacia patellae”, often raises the same fear: cartilage damage that was missed, or that is still worsening. Cartilage can be part of that story—but it is rarely the whole story, and a scan result on its own is not a verdict.

Inside the knee, articular cartilage is the smooth, low‑friction surface coating the ends of the bones, while the meniscus is a tough, rubbery “spacer” that helps spread load across the joint. When either is compromised, symptoms are often described as a deep, aching, load‑related pain (for example after a long walk, a run, or repeated stairs) rather than a sharp, skin‑level pain. With patellofemoral problems, discomfort is classically felt around or behind the kneecap and may flare with sitting with the knee bent, squatting, or going up and down stairs, sometimes with “grating” (crepitus) on straightening.[1]

With ACL injuries, associated structural damage (for example to the meniscus and/or cartilage) is common. This matters because combined injuries are one reason some knees remain irritable long after the ligament has been stabilised; in a large multicentre revision ACL reconstruction cohort (n≈1,234), meniscal pathology and articular cartilage damage at surgery—particularly medial meniscal excision and patellofemoral cartilage lesions—were among the most consistent predictors of worse patient-reported scores and lower activity at 6-year follow-up.[2]

“Hidden” cartilage damage is also plausible in some people. Quantitative 3‑Tesla MRI research has found increased deep‑zone cartilage T2 relaxation times after ACL injury even when cartilage thickness still looks normal—suggesting early compositional change (matrix and water‑content change) that may not stand out on routine imaging.[3] These changes do not automatically explain pain, but they can help explain why a knee behaves as if it has less tolerance to impact and repetition than expected.

For runners, an MRI report of chondromalacia patellae usually points to early degeneration/softening of the cartilage under the patella rather than advanced “bone-on-bone” arthritis; classic symptom descriptions include pain after use, stiffness after sitting, and grating on movement.[1,4] Because articular cartilage has limited spontaneous healing capacity, management is often framed around symptom improvement, optimising mechanics/load, and delaying osteoarthritis risk rather than promising that cartilage will fully “normalise”.[5] The practical take‑home is that symptoms and imaging often don’t match neatly: some people have visible cartilage change with little pain, and others have significant pain with only subtle findings, including when the label is closer to patellofemoral pain syndrome than true structural breakdown.

Why does my knee still hurt after ACL or meniscus surgery

A stable graft and a “successful” operation can still leave a knee that is biologically irritated. One reason is that the original injury is often a package deal: ACL tears commonly involve other structures such as the meniscus and/or articular cartilage, and those combined injuries can increase the risk of earlier osteoarthritis when management is suboptimal.

Within the first few years after reconstruction, MRI studies commonly find cartilage lesions even in people who have otherwise returned to day-to-day function. In a 107-person cohort scanned at 1 year after ACL reconstruction, tibiofemoral cartilage lesions were seen in 49% and patellofemoral lesions in 44%; over the next 5 years, higher global and regional adiposity predicted a greater risk of those lesions worsening.[6] Taken together, that pattern suggests that ongoing joint “load” factors (including body composition) may influence whether the knee continues to settle, or continues to deteriorate structurally.

The meniscus also matters because it shares and spreads load. A 2024 systematic review of posterior medial meniscus injuries reported osteoarthritis progression in about 51% after meniscectomy versus about 21% after meniscal repair, with better functional scores after repair.[7] This helps explain a familiar clinical story: a knee may feel improved in the months after meniscus surgery, then become more persistently sore with impact or long walks several years later as cartilage loading accumulates.

In more complex cases, “what was left behind” can show up in longer-term outcome data. In a multicentre revision ACL reconstruction cohort (n≈1,234) with 6-year follow-up, meniscal pathology and articular cartilage damage at surgery—particularly medial meniscal excision and patellofemoral cartilage lesions—were among the most consistent predictors of worse patient-reported scores and lower activity.[2]

Standard scans do not always capture early cartilage stress. Quantitative 3‑Tesla MRI work (T2 mapping) has shown increased deep-zone cartilage T2 after ACL injury even when cartilage thickness is still preserved, suggesting compositional change before obvious thinning;[3] these techniques are not yet routine in many clinical pathways, but they support the idea that a knee can have reduced “tolerance” despite a relatively unremarkable conventional MRI.

A genuine rehabilitation plateau tends to look less like expected post-operative ache and more like a repeatable pattern with a clear trigger. Red flags that often prompt a more detailed review include:

• Swelling or recurrent effusions after modest load (for example, a short run or stair session).
• Pain that reliably blocks strengthening progress despite graded rehab.
• Mechanical symptoms such as clicking, catching or locking—classically linked with meniscal pathology.
• A sense of “giving way”, particularly when paired with swelling or mechanical symptoms.

What does chondromalacia patella on MRI mean for runners

An MRI report that lists “chondromalacia patellae” is usually describing early stress or early wear in the smooth cartilage under the kneecap, rather than “bone-on-bone” arthritis. Classic descriptions include roughening/softening of the patellar cartilage with grating on movement, pain after use, and stiffness after sitting.[1] Chondromalacia is also common in young, often athletic individuals, and is reported as more prevalent in women.[4] Articular cartilage has limited spontaneous healing capacity, so the practical goal is often symptom control and reducing further overload, rather than promising that the cartilage will fully “normalise”.[5]

The label also sits in the same clinical territory as patellofemoral pain syndrome (PFPS). PFPS is a symptom-based diagnosis (front-of-knee pain linked to how the kneecap and femur interact) and can be very symptomatic even when MRI changes are subtle. That mismatch cuts both ways: mild chondromalacia on MRI can be an incidental finding, and significant pain can occur with little visible cartilage change—so the scan is only one part of the picture.

Common phrases in MRI reports tend to map to a rough “severity ladder”, even though different radiologists may word things differently:

• “Grade I–II chondromalacia”: early softening or surface roughening rather than a deep defect.
• “Fissuring” or “fraying”: small cracks or a shaggy surface, suggesting repeated shear or compression.
• “Full-thickness defect”: cartilage loss down to bone in that spot.
• “Subchondral bone oedema”: bone marrow swelling under the cartilage, often read as a sign of higher local stress.

Several studies link chondromalacia to load and alignment factors common in runners: overuse/high-impact work, previous trauma, patellofemoral instability, bony anatomic variations (including measures related to trochlear shape), abnormal patellar kinematics or maltracking, and muscle weakness/imbalance.[4] A large isokinetic series (about 690 tests) found higher pain levels and lower knee flexor/extensor strength in people with chondromalacia than controls (p<0.001), supporting the idea that neuromuscular capacity and pain often travel together.[8]

Anatomy can also make some knees more vulnerable. A 2025 MRI analysis reported that, compared with controls, chondromalacia patients had a shallower trochlear groove (reduced trochlear depth) and a wider groove shape (increased sulcus angle), alongside altered patellar tilt (all p<0.001)—a pattern consistent with patellofemoral incongruence and maltracking.[9] In trochlear dysplasia, a separate 363-knee MRI series found full-thickness patellar defects in 25.1%, with supratrochlear spur height correlating with those defects (alongside age and higher BMI).[10] These structural features are not a life sentence, but they help explain why symptoms can flare with high-compression tasks (stairs, hills, deep knee bend) and why rehab typically prioritises strength, control, and load management alongside any imaging findings.

How do specialists find hidden cartilage damage

Specialists usually begin with the timeline rather than the scan: the mechanism of the original injury, what was done at surgery (for example, meniscal repair versus meniscectomy), and how symptoms changed as rehabilitation and training load increased. Details that often matter include whether pain is mainly “start-up” stiffness after sitting, whether swelling follows a predictable trigger (such as a 10–15 minute run), and whether there are mechanical symptoms (clicking, catching) or episodes of giving way alongside pain.

The physical examination then tests whether the symptoms behave like a cartilage-/patellofemoral-driven problem, a meniscal problem, or a mix. Common anchors include joint-line tenderness, a check for effusion, range-of-motion limits (especially loss of full extension), and patellofemoral signs such as pain with patellar compression and audible or palpable crepitus on knee extension. Alignment (varus/valgus) and movement quality are also assessed: a single-leg squat can reveal dynamic valgus, hip control issues, or apprehension that increases patellofemoral contact stress.

Imaging is used to answer specific questions raised by the history and examination. Standard MRI can help visualise patellar cartilage lesions and patellofemoral morphology in people with chondromalacia patellae and related anterior-knee pain presentations.[9] In patellofemoral pain presentations, symptoms classically worsen with stairs, squatting, or prolonged sitting with the knee bent, so the scan is often reviewed with those aggravating activities in mind rather than read as a stand-alone diagnosis. Plain X-rays are also commonly added in UK practice when there is concern for more established osteoarthritis changes.

When symptoms are substantial but routine MRI looks relatively reassuring, the question becomes whether the issue is an early cartilage “quality” problem rather than a visible surface defect. Quantitative MRI approaches (such as T2 mapping at 3T) have demonstrated deep-zone compositional cartilage changes after ACL injury even when cartilage thickness is preserved, supporting the idea that early damage can be present before obvious thinning;[3] these techniques, however, are not standard across all pathways and are usually reserved for specialist or research settings.

Across UK settings, the key safeguard is integration rather than escalation: MRI findings are weighed against the symptom pattern and the examination, because cartilage changes and degenerative meniscal signal can be incidental, especially with age, while pain can also be driven by non-cartilage contributors such as synovial irritation or altered neuromuscular control. The practical output of the assessment is therefore a ranked problem list (for example, patellofemoral overload plus deconditioning, with or without a focal defect) that guides the next step in a staged plan.

What are my treatment options from rehab to injections and surgery

A staged plan tends to work best when each step has a clear job to do—rather than treating “injections” as one vague middle rung. In practice, decisions are usually easier when options are grouped by aim (calming inflammation, improving joint mechanics, or supporting tissue repair), and when “success” is defined as measurable changes in pain, swelling and function rather than a perfect MRI report.

Rehabilitation and load management (first line)

For patellofemoral cartilage pain and chondromalacia presentations, conservative care is typically the starting point even when previous rehab has plateaued, because programmes may fail when they are not progressive, not specific, or not monitored. Expert reviews describe management as activity/load modification plus physiotherapy focused on correcting maltracking and building quadriceps and hip strength, aiming to improve symptoms and potentially delay progression rather than “normalising” cartilage.[5]

For running-related symptoms, load changes are usually short-term and targeted: reducing weekly mileage, limiting downhill running, avoiding deep knee flexion under load (for example, repeated deep squats), and using lower-impact conditioning (cycling or pool running) while strength and control are rebuilt. In active populations with chondromalacia, a large isokinetic dataset (≈690 tests) reported higher pain and lower knee flexor/extensor strength than controls (p<0.001), supporting the idea that symptom flares and capacity deficits often travel together.[8]

In post-ACL reconstruction settings, modifiable risk factors can also matter. A longitudinal MRI cohort (107 people) reported cartilage lesions at 1 year in 49% (tibiofemoral) and 44% (patellofemoral), with greater adiposity predicting worsening over 5 years, so weight and body composition are sometimes treated as part of cartilage protection rather than a separate “fitness” issue.[6]

Injection options (symptom-modulating support)

Injections are commonly used as adjuncts when pain or recurrent swelling is blocking rehabilitation—so the reasonable yardstick is often whether they help re-engage with strengthening, tolerate stairs or return to controlled running volumes, and reduce flare frequency over the following weeks. In UK practice, the options are often discussed in three buckets:

• Anti-inflammatory pain flares: corticosteroid injections may be considered for short-term symptom relief in selected cases, but they are not presented as cartilage-restoring.
• Viscosupplementation/lubrication: hyaluronic acid is sometimes used in osteoarthritic knees where symptoms fit that pattern.
• Biologic symptom support: platelet-rich plasma (PRP) is used in some pathways, although published results are mixed and patient selection (diagnosis, stage, load drivers) matters.

When cartilage restoration or regeneration is considered

If there is a focal cartilage defect, persistent functional limitation, or structural drivers such as malalignment that keep provoking symptoms despite optimised rehab, specialist reviews describe escalation to procedures such as cartilage restoration techniques and, in selected cases, realignment osteotomies—aiming to improve symptoms and delay osteoarthritis rather than guaranteeing “new normal” cartilage.[5]

Some clinics also offer injectable scaffold approaches for selected focal cartilage defects. As with many cartilage interventions (particularly in athletic populations), long-term head-to-head comparative data against other options can be limited, so escalation is usually framed around goals (pain control, swelling reduction, function), trade-offs, and the strength of evidence for the specific knee pattern.

How can I protect my knee and when should I see a specialist

Cartilage protection usually comes down to three levers that can be started on the same week: load, capacity, and recovery. In post-ACL settings, body composition may be a meaningful modifiable factor: in a 107-person cohort, cartilage lesions were already common on MRI at 1 year (49% tibiofemoral and 44% patellofemoral), and greater adiposity predicted worsening over the following 5 years.[6] In patellofemoral cartilage pain, conservative plans typically centre on load modification plus strengthening to reduce patellar contact stress, acknowledging limited spontaneous healing capacity of articular cartilage and aiming for symptom control and slowing progression rather than a “perfect” knee overnight.[5]

Practical actions commonly used in clinic can be kept simple and measurable:

• Body weight / composition (5-year signal): where relevant, reducing excess adiposity is treated as a cartilage-risk lever because MRI lesion worsening after ACL reconstruction tracked with higher body fat over 5 years.[6]
• Strength capacity (60°/s marker): chondromalacia populations have shown higher pain and lower knee flexor/extensor strength on isokinetic testing at 60°/s (p<0.001), supporting a consistent programme that targets quadriceps, hamstrings, hips and trunk control.[8]
• Pacing and flare control (24–48 hour rule): activity changes are often judged by the knee’s next-day response—especially swelling—rather than by how it feels mid-session.

Trend matters more than a single bad day, so monitoring is usually structured over 2–4 weeks rather than guessed from memory. Many people use a brief diary that logs a 0–10 pain score, any visible swelling/effusion, and one or two function anchors (for example, stair tolerance on a “one-flight” test, walking distance in kilometres, or weekly running volume). A pattern where the same trigger repeatedly produces a flare within 24–48 hours is often more informative than the wording of an MRI impression.

Escalation beyond GP or community physiotherapy is generally considered when there are clear decision-points rather than vague worry: persistent swelling, mechanical symptoms such as “locking” or “catching”, repeated giving way, or pain that still blocks progression after 8–12 weeks of structured, monitored rehabilitation (recognising that this is a guide and progress is criteria-based). Specialist review does not automatically mean surgery; it often aims to clarify whether symptoms fit a patellofemoral overload pattern, a focal cartilage defect, ongoing meniscal problems, or a combination, and to refine non-operative care first.

The practical endpoint is a clear plan built around a small set of tracked measures (pain, swelling, and one or two function tests), plus explicit thresholds for when the knee is settling versus when it is repeatedly flaring.

1. [1] A STUDY ON THE CAUSATIVE FACTORS INDUCING CHONDROMALACIA PATELLAE. (2025). https://doi.org/10.36713/epra23320 https://doi.org/10.36713/epra23320